Celldex Therapeutics, Inc. (NASDAQ:CLDX) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Celldex Therapeutics, Inc. (NASDAQ:CLDX - Get Free Report) has earned an average recommendation of "Moderate Buy" from the eleven ratings firms that are currently covering the firm, MarketBeat reports. Two research analysts have rated the stock with a sell rating, one has given a hold rating, seve...